Fundraising Focus ProQuest Investments manages over $875 million with a fourth fund closed at $425 million, indicating active fundraising and capacity to participate in multiple rounds. This suggests a potential opportunity to intro strategic fundraising conversations, co-investment opportunities, and sponsor-aligned syndication with other venture firms.

Healthcare Specialization Specialization in healthcare, with strong emphasis on therapeutics and drug discovery technologies, positions ProQuest as a potential partner for early to late-stage biotech ventures. Leverage opportunities to pitch therapeutics platforms, molecular analysis tools, and clinical-stage programs aligned to their thesis.

Geographic Reach Multiple offices in Princeton, San Diego, and Montreal imply a broad geographic footprint and access across major biotech hubs. This facilitates cross-border deal flow, regional co-investors, and potential introductions to local portfolio companies seeking expansion or partnerships.

Investment Stage Breadth Invests across seed to late-stage healthcare companies, suggesting openness to diverse deal structures, syndication with co-investors, and flexible financing terms. Explore opportunities for follow-on rounds, bridge loans, or strategic exits with portfolio companies.

Active Portfolio Activity Recent exit-like activity noted via participation in a $32M financing round for ReVision Optics, indicating an active deal cadence and willingness to co-lead or participate in substantial financings alongside other investors. Target partnerships with portfolio companies for scale, strategic partnerships, or exits.